Aroa BiosurgeryASX:ARX +0.85%63 OCF Yield % is 4.30 as of Jun. 28, 2026. GuruFocus rates ASX:ARX with a GF Score™ of 63/100 and a GF Value™ of A$0.80 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 852 Medical Devices & Instruments companies, Aroa Biosurgery ranks better than 62.09% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Aroa Biosurgery's OCF Yield % or its related term are showing as below:
ASX:ARX'
s OCF Yield % Range Over the Past 10 Years
Min: -4.93 Med: -1.5 Max: 4.85
Current: 4.3
During the past 7 years, the highest OCF Yield % of Aroa Biosurgery was 4.85%. The lowest was -4.93%. And the median was -1.50%.
ASX:ARX's OCF Yield % is ranked better than 62.09% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.785
vs ASX:ARX: 4.30
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Aroa Biosurgery OCF Yield % Related Terms
Aroa Biosurgery OCF Yield % Historical Data
* Premium members only.
The historical data trend for Aroa Biosurgery's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aroa Biosurgery's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aroa Biosurgery OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Aroa Biosurgery's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aroa Biosurgery (ASX:ARX) has a OCF Yield % of 4.30 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Aroa Biosurgery and its competitors. According to the industry distribution chart, Aroa Biosurgery ranks #323 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 37.9%.
Is Aroa Biosurgery's OCF Yield % too high?
Aroa Biosurgery's current OCF Yield % is 4.30. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Aroa Biosurgery's value of 4.30 is 140.9% above this industry median. Based on the distribution chart, Aroa Biosurgery ranks #323 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aroa Biosurgery has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aroa Biosurgery's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aroa Biosurgery ranks #323 out of 852 companies for OCF Yield %. This puts Aroa Biosurgery in the upper half of its industry. The industry median OCF Yield % is 1.79. Aroa Biosurgery's value of 4.30 is 140.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aroa Biosurgery's current OCF Yield % of 4.30 is 140.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Aroa Biosurgery and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aroa Biosurgery's current OCF Yield % is 4.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aroa Biosurgery stock overvalued right now?
Based on GuruFocus' analysis, Aroa Biosurgery (ASX:ARX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.80, compared to a current price of A$0.59 — trading 26.3% below its estimated fair value. The current OCF Yield % is 4.30 and 140.9% above the Medical Devices & Instruments industry median of 1.79. Aroa Biosurgery's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Aroa Biosurgery (ASX:ARX), the current OCF Yield % is 4.30 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aroa Biosurgery (ASX:ARX) Overvalued in 2026?
Based on GuruFocus' analysis, Aroa Biosurgery stock appears to be undervalued.
The current stock price of A$0.59 is trading 26.3% below its estimated GF Value™ of A$0.80.
GuruFocus considers Aroa Biosurgery to be Modestly Undervalued.
Key valuation signals for ASX:ARX:
OCF Yield %: 4.30
GF Value™: A$0.80 vs. price of A$0.59 (26.3% below fair value)
Industry Position: 140.9% above the Medical Devices & Instruments median (#323 of 852)
No single metric tells the full story. See the ASX:ARX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
63GF Score
Get the complete analysis for ASX:ARX
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ARX has been successfully added to your 
